Xu L, Xuan H, Shi X
Epigenomics. 2025; 17(3):193-208.
PMID: 39929233
PMC: 11812348.
DOI: 10.1080/17501911.2024.2447807.
Wienen F, Nilson R, Allmendinger E, Peters S, Barth T, Kochanek S
Mol Ther Oncol. 2025; 32(4):200909.
PMID: 39758252
PMC: 11699628.
DOI: 10.1016/j.omton.2024.200909.
Dawson L, Alshawabkeh M, Schroer K, Arakrak F, Ehrhardt A, Zhang W
Eng Microbiol. 2024; 4(1):100140.
PMID: 39628785
PMC: 11611009.
DOI: 10.1016/j.engmic.2024.100140.
Lu Z, Haghollahi S, Afzal M
Cancers (Basel). 2024; 16(20).
PMID: 39456568
PMC: 11506301.
DOI: 10.3390/cancers16203474.
Ramos-Gonzalez M, Tarique M, Batra L, Arguc F, Garza-Morales R, Shirwan H
Vaccines (Basel). 2024; 12(3).
PMID: 38543974
PMC: 10974162.
DOI: 10.3390/vaccines12030340.
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma.
Liu X, Zhao Z, Dai W, Liao K, Sun Q, Chen D
Cancers (Basel). 2023; 15(17).
PMID: 37686584
PMC: 10486426.
DOI: 10.3390/cancers15174308.
Epithelial tissue confinement inhibits cell growth and leads to volume-reducing divisions.
Devany J, Falk M, Holt L, Murugan A, Gardel M
Dev Cell. 2023; 58(16):1462-1476.e8.
PMID: 37339629
PMC: 10528006.
DOI: 10.1016/j.devcel.2023.05.018.
Human Adenovirus Gene Expression and Replication Is Regulated through Dynamic Changes in Nucleoprotein Structure throughout Infection.
Jennings M, Parks R
Viruses. 2023; 15(1).
PMID: 36680201
PMC: 9863843.
DOI: 10.3390/v15010161.
Merkel cell polyomavirus small T antigen is a viral transcription activator that is essential for viral genome maintenance.
Rapchak K, Yagobian S, Moore J, Khattri M, Shuda M
PLoS Pathog. 2022; 18(12):e1011039.
PMID: 36574443
PMC: 9829177.
DOI: 10.1371/journal.ppat.1011039.
Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirus.
Harryvan T, Golo M, Dam N, Schoonderwoerd M, Farshadi E, Hornsveld M
Cancer Gene Ther. 2022; 29(12):1918-1929.
PMID: 35869278
PMC: 9750869.
DOI: 10.1038/s41417-022-00507-9.
Clinical advances in oncolytic virotherapy for pediatric brain tumors.
Ghajar-Rahimi G, Kang K, Totsch S, Gary S, Rocco A, Blitz S
Pharmacol Ther. 2022; 239:108193.
PMID: 35487285
PMC: 9709696.
DOI: 10.1016/j.pharmthera.2022.108193.
Characterization and Functional Study of Reveals Its Effect on Cell Proliferation in HEK293T Cells.
Chen Y, Jiang Y, Lao J, Zhou Y, Su L, Huang X
Genes (Basel). 2022; 13(2).
PMID: 35205432
PMC: 8872254.
DOI: 10.3390/genes13020388.
KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer.
Kim K, Kabra A, Kim D, Xue Y, Huang Y, Hou P
Sci Adv. 2022; 8(7):eabl4618.
PMID: 35171684
PMC: 8849394.
DOI: 10.1126/sciadv.abl4618.
Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.
Van Gils J, Magdinier F, Fergelot P, Lacombe D
Genes (Basel). 2021; 12(7).
PMID: 34202860
PMC: 8303114.
DOI: 10.3390/genes12070968.
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers.
Waddell A, Huang H, Liao D
Cancers (Basel). 2021; 13(12).
PMID: 34201346
PMC: 8229436.
DOI: 10.3390/cancers13122872.
Recent Advances in Novel Antiviral Therapies against Human Adenovirus.
Saha B, Parks R
Microorganisms. 2020; 8(9).
PMID: 32842697
PMC: 7563841.
DOI: 10.3390/microorganisms8091284.
Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells.
Ehrke-Schulz E, Heinemann S, Schulte L, Schiwon M, Ehrhardt A
Cancers (Basel). 2020; 12(7).
PMID: 32708897
PMC: 7409089.
DOI: 10.3390/cancers12071934.
Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.
Del Papa J, Clarkin R, Parks R
Cancer Gene Ther. 2020; 28(7-8):745-756.
PMID: 32606392
DOI: 10.1038/s41417-020-0192-9.
Adenovirus 5 E1A Interacts with E4orf3 To Regulate Viral Chromatin Organization.
Soriano A, Crisostomo L, Mendez M, Graves D, Frost J, Olanubi O
J Virol. 2019; 93(10).
PMID: 30842325
PMC: 6498062.
DOI: 10.1128/JVI.00157-19.
Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.
Kim B, Coyaud E, Laurent E, St-Germain J, Van de Laar E, Tsao M
Mol Cell Proteomics. 2017; 16(10):1864-1888.
PMID: 28794006
PMC: 5629269.
DOI: 10.1074/mcp.M116.064451.